MAP2K7 and cancer: Cancer cell proliferation is driven in part by altered intracellular signaling downstream of hyperactive growth factor receptors at the PM, including the engagement of the Ras-RAF-MEK-ERK and the PI3K/Akt pathways, as well as the crosstalk between signaling and endocytosis.